Filing Details

Accession Number:
0001104659-24-078786
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-07-10 08:30:11
Reporting Period:
2024-07-08
Accepted Time:
2024-07-10 08:30:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1429260 Fortress Biotech Inc. FBIO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
941841 Md A Lindsay Rosenwald C/O Fortress Biotech, Inc.
1111 Kane Concourse Suite 301
Bay Harbor Islands FL 33154
President, Ceo & Chairman Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Series A Cumulative Perpetual Preferred Stock Acquisiton 2024-07-08 5,000 $7.35 117,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on July 8, 2024 was $7.29 to $7.47. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price.